Sterilization Modality Selection: Role of Sterility Assurance Subject Matter Expert.

Q4 Medicine
Jami McLaren, Joyce M Hansen, Vu Le
{"title":"Sterilization Modality Selection: Role of Sterility Assurance Subject Matter Expert.","authors":"Jami McLaren,&nbsp;Joyce M Hansen,&nbsp;Vu Le","doi":"10.2345/0899-8205-55.s3.67","DOIUrl":null,"url":null,"abstract":"<p><p>Selection of a sterilization modality for a medical device is a critical decision that requires sterility assurance subject matter experts (SME)s to work collaboratively with various company functions. The sterility assurance SME is responsible and accountable for the sterilization modality decision for a product. The modality selection process starts with the sterility assurance SME partnering with research and development to ensure that the sterilization modality allows the device to deliver its intended function in patient care. After the sterilization modality is selected, the sterility assurance SME needs to work with other partners, including quality, supply chain/logistics, operations, and regulatory, to ensure that the selected sterilization modality is appropriately integrated into the end-to-end process. Collaborative partnerships between sterility assurance experts and key partners regarding sterilization modality selection reduce the potential for negative impacts within the end-to-end sterility assurance process, including impacts on product functionality, increased regulatory approval timelines, and inefficiencies and risks throughout the supply chain. This article describes aspects of a comprehensive approach to sterilization modality selection, including critical information necessary to address each of the key considerations.</p>","PeriodicalId":35656,"journal":{"name":"Biomedical Instrumentation and Technology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655698/pdf/i0899-8205-55-s3-67.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomedical Instrumentation and Technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2345/0899-8205-55.s3.67","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1

Abstract

Selection of a sterilization modality for a medical device is a critical decision that requires sterility assurance subject matter experts (SME)s to work collaboratively with various company functions. The sterility assurance SME is responsible and accountable for the sterilization modality decision for a product. The modality selection process starts with the sterility assurance SME partnering with research and development to ensure that the sterilization modality allows the device to deliver its intended function in patient care. After the sterilization modality is selected, the sterility assurance SME needs to work with other partners, including quality, supply chain/logistics, operations, and regulatory, to ensure that the selected sterilization modality is appropriately integrated into the end-to-end process. Collaborative partnerships between sterility assurance experts and key partners regarding sterilization modality selection reduce the potential for negative impacts within the end-to-end sterility assurance process, including impacts on product functionality, increased regulatory approval timelines, and inefficiencies and risks throughout the supply chain. This article describes aspects of a comprehensive approach to sterilization modality selection, including critical information necessary to address each of the key considerations.

灭菌方式选择:无菌保证主题专家的作用。
为医疗器械选择灭菌方式是一项关键决策,需要无菌保证主题专家(SME)与公司各职能部门协同工作。无菌保证SME对产品的灭菌方式决定负责。模式选择过程从无菌保证SME与研发合作开始,以确保灭菌模式允许设备在患者护理中发挥其预期功能。选择灭菌方式后,无菌保证中小企业需要与其他合作伙伴合作,包括质量、供应链/物流、运营和监管,以确保所选择的灭菌方式适当地集成到端到端流程中。无菌保证专家和主要合作伙伴之间在灭菌方式选择方面的合作伙伴关系减少了端到端无菌保证过程中潜在的负面影响,包括对产品功能的影响,增加了监管审批时间表,以及整个供应链的低效率和风险。本文描述了灭菌方式选择的综合方法的各个方面,包括解决每个关键考虑因素所需的关键信息。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Biomedical Instrumentation and Technology
Biomedical Instrumentation and Technology Computer Science-Computer Networks and Communications
CiteScore
1.10
自引率
0.00%
发文量
16
期刊介绍: AAMI publishes Biomedical Instrumentation & Technology (BI&T) a bi-monthly peer-reviewed journal dedicated to the developers, managers, and users of medical instrumentation and technology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信